Notice of Intent to Issue Sole Source for Hormone Analysis

The Centers for Disease Control and Prevention (CDC), (CDC National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention) hereby announces its intent to issue a sole source order/contract to University of Wisconsin System (Wisconsin National Primate Resarch Center). The NAICS code for this acquisition is 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). The Centers for Diesase Control and Prevention is looking for a vendor that conducts research on nonhuman primates using the same methodology and hormone analysis University of Wisconsin System has been doing so samples will be comparable to existing data analysis. Vendors must provide comparable data with the sensitivity and specificity for hormone levels in the specimens that the program office has established over the years. The Laboratory Branch supports Division of HIV/AIDS Prevention’s (DHAP) goals in HIV prevention as they pertain to clinical studies, viral transmission, diagnosis and incidence, intervention research with microbicides, vaccines, and chemoprophylaxis as well as investigates other human and zoonotic retroviruses. The Lab Branch also requires assays for monitoring and quantitating hormone levels that may influence prophylactic treatment in our animal modeling system. Monitoring hormones associated with the menstrual cycle in macaques is a developed assay service and is necessary for the efforts of our work towards preventing HIV transmission. The Government requires Contractor services to perform analysis assays of the Quantitative Hormone Testing on Macaque specimens and provide quantitative data for the Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Heptatitis, STD, and TB Prevention (NCHHSTP), Division of HIV/AIDS Prevention, Laboratory Branch. The Vendor shall have the trained technician, expertise, capacity to perform Macaque Hormone analysis (such as Progesterone and LNG/EE) on NHP specimens within 2 weeks of receiving each batch of samples and provide results/data to CDC within 3 weeks or less of receiving the batch of samples. The Vendor shall have a minimum of 5 years of experience providing such assays services on NHP specimens. This action is for supplies which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit quotations. This is not a request for competitive quotations ; however, the Government will review any/all product, capabilities, and pricing information submitted prior to the closure of this notice. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any responses should be emailed to Zachary Perez (CTR) at [email protected] by June 16th, 2021 at 1:00 P.M. ET.